ArticleCureus2024

Durable Response to Combined Nivolumab, Lenvatinib, and Radiation Therapy Against Oligometastatic Hepatocellular Carcinoma.

Sewoon Chun et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.